Business Wire
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
📈
AI Sentiment
Highly Positive
9/10
- Home
- ANGO
ANGO
AngioDynamics Inc.
as of 02-06-2026 4:00pm EST
$10.56
+$0.50
+4.97%
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
| Founded: | 1988 | Country: | United States |
| Employees: | N/A | City: | LATHAM |
| Market Cap: | 427.0M | IPO Year: | 2004 |
| Target Price: | $19.33 | AVG Volume (30 days): | 675.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.67 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.27 - $13.99 | Next Earning Date: | 01-06-2026 |
| Revenue: | $307,306,000 | Revenue Growth: | 7.26% |
| Revenue Growth (this year): | 9.11% | Revenue Growth (next year): | 4.94% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -9329000.0 | FCF Growth: | N/A |
AI-Powered ANGO Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 73.72%
73.72%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest AngioDynamics Inc. News
ANGO Breaking Stock News: Dive into ANGO Ticker-Specific Updates for Smart Investing
Compare ANGO vs Leading Stocks
See how ANGO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ANGO AngioDynamics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.